Results 211 to 220 of about 2,712,287 (341)

Effectiveness and tolerability of liraglutide as add‐on treatment in patients with obesity and high‐frequency or chronic migraine: A prospective pilot study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess whether glucagon‐like‐peptide‐1 receptor (GLP‐1R) agonists could serve as a novel prophylactic treatment for migraine in patients with obesity. Background Increased intracranial pressure (ICP) is speculated to play a role in migraine mechanisms, as chronic migraine and idiopathic intracranial hypertension without ...
Simone Braca, Cinzia Valeria Russo, Antonio Stornaiuolo, Gennaro Cretella, Angelo Miele, Caterina Giannini, Roberto De Simone   +6 more
wiley   +1 more source

Clinical and psychological predictors of sleep quality in chronic migraine: a preliminary retrospective analysis study. [PDF]

BMC Neurol
Chen YM, Wang JH, Liang CS, Lin YK, Yang FC.   +4 more
europepmc   +1 more source

PND13 IMPACT OF CHRONIC (CM) AND EPISODIC MIGRAINE (EM) ON WORK PRESENTEEISM IN 9 COUNTRIES

, 2009
SF Varon, CT Burk, DC Buse, AK Kawata, KA Payne, Arnold Blumenfeld, RB Lipton   +6 more
openalex   +1 more source

PND42 Cost-Effectiveness of Onabotulinumtoxin-a for the Prophylaxis of Chronic Migraine [PDF]

, 2012
Matteo Ruggeri, A. Carletto, Marco Marchetti   +2 more
openalex   +1 more source

Fremanezumab for the Preventive Treatment of Chronic Migraine

New England Journal of Medicine, 2017
S. Silberstein, D. Dodick, M. Bigal, P. Yeung, P. Goadsby, Tricia Blankenbiller, M. Grozinski‐Wolff, Ronghua Yang, Yuju Ma, E. Aycardi   +9 more
semanticscholar   +1 more source

Physical activity as a predictor of fremanezumab response in chronic migraine - the Phy-Fre-Mig study. [PDF]

J Headache Pain
Sierra-Mencía Á, Recio-García A, García-Azorín D, de la Torre AJM, González IR, Guerrero-Peral ÁL.   +5 more
europepmc   +1 more source

Quality of Life and Emotional Functioning in Youth With Chronic Migraine and Juvenile Fibromyalgia [PDF]

, 2013
Susmita Kashikar‐Zuck, Marium Zafar, Kimberly A. Barnett, Brandon S. Aylward, D. Strotman, Shalonda K. Slater, Janelle R. Allen, Susan L. LeCates, Marielle A. Kabbouche, Tracy V. Ting, Andrew D. Hershey, Scott W. Powers   +11 more
openalex   +1 more source

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary: This randomized trial was designed to test the effectiveness and safety of rimegepant for the acute treatment of migraine among adults in Japan. Results indicated that rimegepant was more effective than placebo, and the 75 mg dose was observed to be more effective than the 25 mg dose.
Koichi Ikeda, Yasuhiko Matsumori, Masako Kudo, Tomofumi Ishikawa, Yuko Hoshino, Hiroki Yoshimatsu, Alexandra Thiry, Akio Arakawa, Robert Croop, Terence Fullerton, Fumihiko Sakai, Takao Takeshima   +11 more
wiley   +1 more source

Dyspareunia and pelvic pain in women with chronic migraine: A retrospective, observational analysis. [PDF]

Headache
Smirnoff L, Moskatel LS.
europepmc   +1 more source

The Psychometric Properties of the Persian Migraine‐Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraines [PDF]

, 2013
Alireza Zandifar, Samaneh Sadat Masjedi, Faraidoon Haghdoost, Fatemeh Asgari, Navid Manouchehri, Mahboobeh Banihashemi, Mohammad Reza Najafi, Abbas Ghorbani, Behzad Zolfaghari, Ali Gholamrezaei, Vahid Shaygannejad, Mohammad Saadatnia   +11 more
openalex   +1 more source